Key Takeaways GSK Plc’s U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion…
Read More »Key Takeaways GSK Plc’s U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion…
Read More »